Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1991 Apr;75(4):201–207. doi: 10.1136/bjo.75.4.201

Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease.

S J Charles 1, P A Meyer 1, P G Watson 1
PMCID: PMC1042320  PMID: 2021584

Abstract

The ocular and systemic features of 10 patients whose Wegener's granulomatosis presented with corneoscleral inflammatory disease are described. Marginal corneal infiltrates were seen in all patients with anterior scleritis and were a valuable sign of disease activity. Nine out of 10 patients had symptoms of systemic vasculitis on presentation; seven had renal impairment; three had chest x-ray abnormalities. Autoantibodies against neutrophil cytoplasmic determinants (ANCA) were present in all cases. In seven patients the scleritis responded well to pulsed immunosuppressive therapy followed by long term oral steroids and cyclophosphamide. Oral steroid therapy alone failed to control severe disease. Corneoscleral disease was not a cause of visual loss. It is important to realise that inflammatory corneoscleral disease may be the presenting feature of a severe systemic vasculitis.

Full text

PDF
201

Images in this article

202Image
on p.202
202Image
on p.202
203Image
on p.203
203Image
on p.203
203Image
on p.203
203Image
on p.203
203Image
on p.203
204Image
on p.204
205Image
on p.205
205Image
on p.205
205Image
on p.205
205Image
on p.205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin P., Green W. R., Sallyer D. C., Walsh F. B., Kleinfelter H. T. Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis. Am J Ophthalmol. 1978 Mar;85(3):311–317. doi: 10.1016/s0002-9394(14)77721-9. [DOI] [PubMed] [Google Scholar]
  2. Bullen C. L., Liesegang T. J., McDonald T. J., DeRemee R. A. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983 Mar;90(3):279–290. doi: 10.1016/s0161-6420(83)34574-7. [DOI] [PubMed] [Google Scholar]
  3. Donald K. J., Edwards R. L., McEvoy J. D. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology. 1976 Apr;8(2):161–169. doi: 10.3109/00313027609094443. [DOI] [PubMed] [Google Scholar]
  4. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  5. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  6. Fauci A. S., Wolff S. M., Johnson J. S. Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. N Engl J Med. 1971 Dec 30;285(27):1493–1496. doi: 10.1056/NEJM197112302852701. [DOI] [PubMed] [Google Scholar]
  7. GODMAN G. C., CHURG J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954 Dec;58(6):533–553. [PubMed] [Google Scholar]
  8. GREENBERG L. H., TANAKA K. R. CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE. JAMA. 1964 May 4;188:423–426. doi: 10.1001/jama.1964.03060310023005. [DOI] [PubMed] [Google Scholar]
  9. Gross W. L., Lüdemann G., Kiefer G., Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1986 Apr 5;1(8484):806–806. doi: 10.1016/s0140-6736(86)91820-9. [DOI] [PubMed] [Google Scholar]
  10. Harrison H. L., Linshaw M. A., Lindsley C. B., Cuppage F. E. Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis. JAMA. 1980 Oct 3;244(14):1599–1600. [PubMed] [Google Scholar]
  11. Hind C. R., Winearls C. G., Lockwood C. M., Rees A. J., Pepys M. B. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol. 1984 Jun;21(6):341–345. [PubMed] [Google Scholar]
  12. Marshall V. Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation. 1974 Mar;17(3):272–275. doi: 10.1097/00007890-197403000-00006. [DOI] [PubMed] [Google Scholar]
  13. McCluskey R. T., Fienberg R. Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases. Hum Pathol. 1983 Apr;14(4):305–315. doi: 10.1016/s0046-8177(83)80116-6. [DOI] [PubMed] [Google Scholar]
  14. Meyer P. A., Watson P. G., Franks W., Dubord P. 'Pulsed' immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye (Lond) 1987;1(Pt 4):487–495. doi: 10.1038/eye.1987.73. [DOI] [PubMed] [Google Scholar]
  15. Pinching A. J., Lockwood C. M., Pussell B. A., Rees A. J., Sweny P., Evans D. J., Bowley N., Peters D. K. Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med. 1983 Autumn;52(208):435–460. [PubMed] [Google Scholar]
  16. STRAATSMA B. R. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol. 1957 Dec;44(6):789–799. doi: 10.1016/0002-9394(76)90784-4. [DOI] [PubMed] [Google Scholar]
  17. Savage C. O., Winearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987 Jun 20;1(8547):1389–1393. doi: 10.1016/s0140-6736(87)90591-5. [DOI] [PubMed] [Google Scholar]
  18. Shillitoe E. J., Lehner T., Lessof M. H., Harrison D. F. Immunological features of Wegener's granulomatosis. Lancet. 1974 Feb 23;1(7852):281–284. doi: 10.1016/s0140-6736(74)92594-x. [DOI] [PubMed] [Google Scholar]
  19. Spalton D. J., Graham E. M., Page N. G., Sanders M. D. Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol. 1981 Aug;65(8):553–563. doi: 10.1136/bjo.65.8.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tervaert J. W., Goldschmeding R., Elema J. D., van der Giessen M., Huitema M. G., van der Hem G. K., The T. H., von dem Borne A. E., Kallenberg C. G. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int. 1990 Feb;37(2):799–806. doi: 10.1038/ki.1990.48. [DOI] [PubMed] [Google Scholar]
  21. Thompson J. F., Chalmers D. H., Wood R. F., Kirkham S. R., Morris P. J. Sudden death following high-dose intravenous methylprednisolone. Transplantation. 1983 Nov;36(5):594–596. [PubMed] [Google Scholar]
  22. Toledo T. M., Harper R. C., Moser R. H. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med. 1971 Jan;74(1):87–91. doi: 10.7326/0003-4819-74-1-87. [DOI] [PubMed] [Google Scholar]
  23. WALTON E. W. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958 Aug 2;2(5091):265–270. doi: 10.1136/bmj.2.5091.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Watson P. G. Vascular changes in peripheral corneal destructive disease. Eye (Lond) 1990;4(Pt 1):65–73. doi: 10.1038/eye.1990.7. [DOI] [PubMed] [Google Scholar]
  25. Watson P., Booth-Mason S. Fluorescein angiography in the differential diagnosis of sclerokeratitis. Br J Ophthalmol. 1987 Feb;71(2):145–151. doi: 10.1136/bjo.71.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES